Enliven Therapeutics Inc (ELVN)

NASDAQ
Currency in USD
23.090
+1.180(+5.39%)
Closed·
After Hours
24.240+1.150(+4.981%)
·
ELVN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
22.21224.110
52 wk Range
13.30030.030
Key Statistics
Edit
Prev. Close
21.91
Open
23.38
Day's Range
22.212-24.11
52 wk Range
13.3-30.03
Volume
1.27M
Average Volume (3m)
412.52K
1-Year Change
0.97%
Book Value / Share
5.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.571
Upside
+75.71%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Enliven Therapeutics Inc News & Analysis

Show more

Enliven Therapeutics Company Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company’s lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.

Compare ELVN to Peers and Sector

Metrics to compare
ELVN
Peers
Sector
Relationship
P/E Ratio
−14.4x−0.6x−0.5x
PEG Ratio
24.38−0.010.00
Price/Book
4.7x0.3x2.6x
Price / LTM Sales
-1.8x3.1x
Upside (Analyst Target)
72.5%120.4%51.1%
Fair Value Upside
Unlock16.2%8.9%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 40.571
(+75.71% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.57 / -0.50
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ELVN Income Statement

FAQ

What Is the Enliven Therapeutics (ELVN) Stock Price Today?

The Enliven Therapeutics stock price today is 23.09.

What Stock Exchange Does Enliven Therapeutics Trade On?

Enliven Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Enliven Therapeutics?

The stock symbol for Enliven Therapeutics is "ELVN."

What Is the Enliven Therapeutics Market Cap?

As of today, Enliven Therapeutics market cap is 1.29B.

What Is Enliven Therapeutics's Earnings Per Share (TTM)?

The Enliven Therapeutics EPS (TTM) is -1.93.

When Is the Next Enliven Therapeutics Earnings Date?

Enliven Therapeutics will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is ELVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Enliven Therapeutics Stock Split?

Enliven Therapeutics has split 1 times.

How Many Employees Does Enliven Therapeutics Have?

Enliven Therapeutics has 65 employees.

What is the current trading status of Enliven Therapeutics (ELVN)?

As of 16 Jun 2025, Enliven Therapeutics (ELVN) is trading at a price of 23.09, with a previous close of 21.91. The stock has fluctuated within a day range of 22.21 to 24.11, while its 52-week range spans from 13.30 to 30.03.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.